New Drug Approvals for 2018
At the completion of this activity, participating pharmacists will be able to identify clinical indications and adverse effects of the new drugs approved by the US FDA in 2018.
New Drug Approvals for 2018 [Pharmacy Technicians]
At the completion of this activity, participating pharmacist technicicans will be able to identify the clinical indications and common adverse effects of new drugs approved by the US FDA in 2018.
An American Journal of Managed Care® Symposium: Managing Treatment Gaps with PCSK9 Inhibitors
This activity features a panel offering unique perspectives on how PCSK9 inhibitors fit into the current treatment landscape of hypercholesterolemia.
What Provider Status and Prescriptive Authority Mean to the Future of Pharmacy
This activity will help pharmacists understand provider status and prescriptive authority and discuss how they will influence the future of pharmacy.